Table 1. Patient Characteristics With Respect to Sex a,b,c.
| Men | Women | Total | |
|---|---|---|---|
| Gender | 144 (47.2) | 161 (52.8) | 305 |
| Age, y | 55 ± 10.9 | 52.8 ± 9.1 | 53.9 ± 1.0 |
| Duration of Diabetes, y | 7.7 ± 6.9 | 8.6 ± 7.3 | 8.2 ± 7.1 |
| BMI, kg/m 2 | 26.48 ± 3.3 | 28 ± 4.6 | 27.5 ± 4.3 |
| Hb, g/dL | 14 ± 1.7 | 12.7 ± 1.4) | 13.4 ± 1.7 |
| Nephropathy | 112 (77.8) | 123 (76.4) | 235 (77.0) |
| Neuropathy | 63 (43.8) | 73 (45.3) | 136 (44.6) |
| Retinopathy | 52 (36.1) | 57 (35.4) | 109 (35.7) |
| GFR, mL/min | 81.3 ± 27.8 | 79.52 ± 29.4 | 80.6 ± 28.6 |
| Oral Hypoglycemic Agents | 112 (48.3) | 120 (51.7) | 232 (76.0) |
| Insulin | 29 (55.7) | 23 (44.2) | 52 (17.0) |
| Insulin Plus Oral Hypoglycemic Agents | 9 (6.3) | 10 (6.2) | 19 (6.2) |
| ACEI | 39 (27.1) | 36 (22.4) | 75 (24.6) |
| ARB | 30 (20.8) | 30 (18.6) | 60 (19.7) |
| Statin | 60 (41.7) | 67 (41.6) | 127 (41.6) |
| Aspirin | 78 (54.2) | 80 (49.7) | 158 (51.9) |
a Abbreviations: BMI, body mass index; Hb, hemoglobin; GFR, glomerular filtration rate; ACEI, angiotensin converting enzyme inhibitor; and ARB, angiotensin receptor blockers.
b Data are presented as mean ± SD or No. (%).
c Two patients did not receive any drug.